Showing results (211-220 of 315) with videos related to

Sort By:
Pageof 32
Frontiers in Immunology|April 6, 2019
Shaping of CD56<sup>bri</sup> Natural Killer Cells in Patients With Steroid-Refractory/Resistant Acute Graft-vs.-Host Disease via Extracorporeal PhotopheresisMing Ni, Lei Wang, Mingya Yang, et al.
Blood|July 3, 2010
Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trialPeter Dreger, Hartmut Döhner, Matthias Ritgen, et al.
Theranostics|May 23, 2017
Peptide vaccination in the presence of adjuvants in patients after hematopoietic stem cell transplantation with CD4+ T cell reconstitution elicits consistent CD8+ T cell responsesMichael Schmitt, Anita Schmitt, Markus Wiesneth, et al.
The Lancet. Haematology|August 21, 2022
Obinutuzumab, acalabrutinib, and venetoclax, after an optional debulking with bendamustine in relapsed or refractory chronic lymphocytic leukaemia (CLL2-BAAG): a multicentre, open-label, phase 2 trialPaula Cramer, Moritz Fürstenau, Sandra Robrecht, et al.
Bone Marrow Transplantation|October 2, 2019
Analysis of data collected in the European Society for Blood and Marrow Transplantation (EBMT) Registry on a cohort of lymphoma patients receiving plerixaforAnna Sureda, Christian Chabannon, Tamás Masszi, et al.
Bone Marrow Transplantation|July 8, 2026
Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMTRyszard Swoboda, Myriam Labopin, Nicolaus Kröger, et al.
Leukemia|December 22, 2022
Retrospective analysis of hematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: conditioning intensity mattersPeter-Martin Bruch, Sascha Dietrich, Herve Finel, et al.
Frontiers in Immunology|August 15, 2020
Association of Country-Specific Socioeconomic Factors With Survival of Patients Who Experience Severe Classic Acute Graft-vs.-Host Disease After Allogeneic Hematopoietic Cell Transplantation. An Analysis From the Transplant Complications Working Party of the EBMTAndrzej Frankiewicz, Christophe Peczynski, Sebastian Giebel, et al.
International Journal of Cancer|February 10, 2019
Idelalisib for optimized CD19-specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patientsSophia Stock, Rudolf Übelhart, Maria-Luisa Schubert, et al.
Bone Marrow Transplantation|May 28, 2025
Improved outcomes over time in patients aged ≥60 years undergoing allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in first complete remission: a large study by the EBMT acute leukemia working partyNour Moukalled, Allain-Thibeault Ferhat, Ali Bazarbachi, et al.
Pageof 32